Lung cancer continues to be a deadly killer. But a pair of medical technology firms, Xillix Technologies of Richmond, British Columbia, and Miravant Medical Technologies of Santa Barbara, Calif., are hoping to join two newly developed technologies that could offer a far more efficient way of catching lung cancer early and destroying it.
Xillix’ contribution is an imaging device, called LIFE-lung, that was approved by the Food and Drug Administration in 1996. The technology uses certain wavelengths of laser light to illuminate the organ; cancerous (and even precancerous) tissues fluoresce in reddish hues. Miravant is one of several companies working on photodynamic therapy (PDT) for treating lung cancer. This technique involves injecting the patient with a photosensitive drug that concentrates in cancerous tissues; when activated by red laser light, the drug destroys these cells.
In clinical trials, PDT technology has proved promising. But one drawback has been that physicians aiming the laser are, in effect, shooting in the dark. The hope is that LIFE-lung would enable the oncologist to aim the laser at the drug-drenched cancer cells far more accurately by illuminating the cancer’s contours.
The combined technology may not win the war against lung cancer, but it may shed light on a promising new strategy.
DeepMind’s cofounder: Generative AI is just a phase. What’s next is interactive AI.
“This is a profound moment in the history of technology,” says Mustafa Suleyman.
What to know about this autumn’s covid vaccines
New variants will pose a challenge, but early signs suggest the shots will still boost antibody responses.
Human-plus-AI solutions mitigate security threats
With the right human oversight, emerging technologies like artificial intelligence can help keep business and customer data secure
Next slide, please: A brief history of the corporate presentation
From million-dollar slide shows to Steve Jobs’s introduction of the iPhone, a bit of show business never hurt plain old business.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.